as of 03-09-2026 3:57pm EST
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | BRANFORD |
| Market Cap: | 273.7M | IPO Year: | N/A |
| Target Price: | $1.00 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $0.84 - $3.10 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 196.35% | Revenue Growth (next year): | 229.03% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
QSI Breaking Stock News: Dive into QSI Ticker-Specific Updates for Smart Investing
AI Sentiment
Neutral
5/10
AI Sentiment
Negative
3/10
See how QSI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "QSI Quantum-Si Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.